Prognostic Value of Some Biochemical Markers in Breast Cancer

Sohag University

Status: Not yet enrolling

Conditions: Breast Cancer Female

Treatments: Diagnostic Test: serum sample for ELIZA

Study type: Observational

Funder types: Other

Identifiers

NCT05699577

Soh-Med-23-01-07

Details and patient eligibility

About

breast cancer is the most common type of cancer in women and first cause of cancer death among them. in Egypt it constitutes 33% of female cancer cases and more than22000 new cases diagnosed each year. there are many prognostic factors for breast cancer as Tumer size, axillary lymph node status, hormonal receptor status, and tumer markers as Ca15-3 and interferon gamma.

Enrollment: 90 estimated patients

Sex: Female

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• female patients aged more than or equal 18 year diagnosed with breast cancer
• metastatic and non-metastatic cancer premenopausal and postmenopausal female positive and negative hormonal receptors and HER2 receptor taking any systemic treatment taking radiotherapy or not

Exclusion criteria

• female patients less than 18 years patients having comorbid disease. patients with double malignancy

Trial design

90 participants in 2 patient groups

metastatic breast cancer

Treatment:

Diagnostic Test: serum sample for ELIZA

non metastatic breast cancer

Treatment:

Diagnostic Test: serum sample for ELIZA